Medtronic updates AneuRx system
This article was originally published in The Gray Sheet
Executive Summary
A newer version of Medtronic's AneuRx AAAdvantage abdominal aortic aneurysm (AAA) stent graft with the Xcelerant delivery system wins FDA approval. Updates to the new system include improved radiopaque markers and stent contouring. Roughly 1.2 mil. people in the United States have AAA, though only 15% are ever diagnosed, according to Medtronic. The AneuRx system was originally launched in the U.S. in 1996 (1"The Gray Sheet" Nov. 28, 2005, p. 9)...
You may also be interested in...
Endovascular AAA Repair Requires Reintervention More Often Than Surgery
Reintervention to address abdominal aortic aneurysm (AAA) repair complications is more common following endovascular procedures than with open surgery, according to Vascular Surgery Chief Jan Blankensteijn, MD, Radboud University Nijmegen Medical Center, The Netherlands
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.